Opportunities of statusmetriya in evaluation of 10-year risk atherosclerosis clinical manifestations development

封面

如何引用文章

全文:

详细

The information content of Framingham, SCORE model and, statusmetriya in the evaluation of the total ten-year cardiovascular risk in an isolated sample of 207 males without clinical manifestations of atherosclerosis was investigated. Detected that most of the observations from persons who had attained over a 10-year period of the combined end point, the models qualified incorrectly, which didn’t meet the requirements of individual risk assessment in a limited sample group of males. Statusmetrichesky algorithm, in contrast to the accepted system of risk stratification, significantly more of the entities attributed to high-risk and significantly less - to the low-risk category. Sensitivity of the model was 73,9%, specificity - 74,7%, the total information value - 74,5%.

作者简介

A. Svistov

Military Medical Academy named after S.M.Kirov

д-р мед. наук, проф., нач. каф. военно-морской и госпитальной терапии

P. Bovtyushko

Military Medical Academy named after S.M.Kirov

канд. мед. наук, преподаватель каф. военно-морской и госпитальной терапии

S. Grishayev

Military Medical Academy named after S.M.Kirov

Email: grishaev_med@mail.ru
д-р мед. наук, доц., зам. нач. каф. военно-морской и госпитальной терапии

V. Nikiforov

North−Western State Medical University named after I.I.Mechnikov, Saint Petersburg

д-р мед. наук, проф. каф. функциональной диагностики

A. Filippov

Military Medical Academy named after S.M.Kirov

д-р мед. наук, проф. 1-й каф. (терапии усовершенствования врачей)

参考

  1. Lloyd-Jones D.M, Larson M.G, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999; 353: 89-92.
  2. Braunwald E, Antman E.M, Beasley J.W et al. ACC/AHA guidelines for the management of patients with unstable angina and non-STsegment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000; 36: 970-1062.
  3. Conroy R.M, Pyorala K, Fitzgerald A.P et al. Estimation of ten year risk of fatal cardiovascular disease in Europa: the SCORE project. Eur Heart J 2003; 24: 987-1003.
  4. Catapano A.L, Reiner Z, De Backer G et al. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society. Atherosclerosis 2011; 217S: S1-S44.
  5. Grundy S.M, Becker D, Luther T.C et al. Adult Treatment Panel III (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults). JAMA 2001; 285: 2486.
  6. Бовтюшко В.Г., Бовтюшко П.В., Поддубский Г.А., Юсупов А.Н. Способ индивидуальной количественной оценки риска развития клинических проявлений атеросклероза. (Патент на изобретение №2385668. Заявление 13.07.2007, зарегистрирован 10.04.2010).

版权所有 © Eco-Vector, 2014

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。

##common.cookie##